Skip to main content
Log in

Proton-pump inhibitors pivotal for nocturnal qastro-oesophaqeal reflux disease in the elderly

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table 1
Figure

References

  1. Thomson ABR. Gastro-oesophageal reflux in the elderly: role of drug therapy in management. Drugs Aging 2001; 18(6): 409–14

    Article  PubMed  CAS  Google Scholar 

  2. Gawrieh S, Shaker R. Medical management of nocturnal symptoms of gastro-oesophageal reflux disease in the elderly. Drugs Aging 2003; 20(7): 509–16

    Article  PubMed  CAS  Google Scholar 

  3. Zhu H, Pace F, Sangaletti O, et al. Features of symptomatic gastroesophageal reflux in elderly patients. Scand J Gastroenterol 1993; 28: 235–8

    Article  PubMed  CAS  Google Scholar 

  4. Farup C, Kleinman L, Sloan S, et al. The impact of nocturnal symptoms associated with gastroesophageal reflux disease on health-related quality of life. Arch Intern Med 2001; 161(1): 45–52

    Article  PubMed  CAS  Google Scholar 

  5. Pilotto A, Franceschi M, Leandro G, et al. Long-term clinical outcome of elderly patients with reflux esophagitis: a six-month to three-year follow-up study. Am J Ther 2002; 9(4): 295–300

    Article  PubMed  Google Scholar 

  6. British National Formulary. No. 46. London: The Pharmaceutical Press, 2003 Sep

  7. Hendel J, Hendel L, Aggestrup S. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease? Aliment Pharmacol Ther 1995; 9(6): 693–7

    Article  PubMed  CAS  Google Scholar 

  8. Hatlebakk JG, Katz PO, Kuo B, et al. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40mg daily. Aliment Pharmacol Ther 1998; 12(12): 1235–40

    Article  PubMed  CAS  Google Scholar 

  9. Flockhart DA, Desta Z, Mahal SK. Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions. Clin Pharmacokinet 2000; 39(4): 295–309

    Article  PubMed  CAS  Google Scholar 

  10. Thjodleifsson B. Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors. Drugs Aging 2002; 19(12): 911–27

    Article  PubMed  CAS  Google Scholar 

  11. Orr WC, Hamish MJ. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression. Aliment Pharmacol Ther 1998; 12(10): 1033–8

    Article  PubMed  CAS  Google Scholar 

  12. Robinson M, Rodriguez-Stanley S, Ciociola AA, et al. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole. Dig Dis Sci 2002; 47(12): 265–73

    Article  PubMed  CAS  Google Scholar 

  13. Xue S, Katz PO, Banerjee P, et al. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors. Aliment Pharmacol Ther 2001; 15(9): 1351–6

    Article  PubMed  CAS  Google Scholar 

  14. Richter JE. Gastroesophageal reflux disease in the older patient: presentation, treatment, and complications. Am J Gastroenterol 2000; 95(2): 368–73

    PubMed  CAS  Google Scholar 

  15. Ramirez B, Richter JE. Promotility drugs in the treatment of gastroesophageal reflux disease. Aliment Pharmacol Ther 1993; 7: 5–20

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Proton-pump inhibitors pivotal for nocturnal qastro-oesophaqeal reflux disease in the elderly. Drugs Ther. Perspect 20, 12–16 (2004). https://doi.org/10.2165/00042310-200420050-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200420050-00005

Keywords

Navigation